Speed dates

find your perfect match!


Here you can find all the companies participating in the Event.

Each Speed Date accomodates max 10 participants per 15 minutes. 

To sign up for the speed dates, please choose four companies that you find interesting, and select your timeslot. When the timeslot is full, please select another timeslot.

ace incubator

ACE Incubator is the university incubator in Amsterdam and is powered by the University of Amsterdam (UvA), Vrije Universiteit Amsterdam (VU), Amsterdam University of Applied Sciences (HvA) and Amsterdam UMC.



Incision is a platform for surgical team performance and online training, founded in Amsterdam by Prof. Dr. Theo Wiggers and various other entrepreneurial professionals, on a mission to improve surgical care. 

Their team believes in sharing surgical skills and making high-quality surgical knowledge for the entire OR team.


College ter Beoordeling van Geneesmiddelen

Iedereen die een medicijn gebruikt moet daarop kunnen vertrouwen. Dit is waar het College ter Beoordeling van Geneesmiddelen (CBG, www.cbg-meb.nl) elke dag aan werkt. Als onafhankelijke autoriteit reguleert het CBG de kwaliteit, werking en veiligheid van een medicijn, en stimuleert het CBG het juiste gebruik door de juiste patiënt. Van een pijnstiller bij de drogist tot een door een medisch specialist voorgeschreven behandeling. Van traditionele tot geheel nieuwe middelen. Voor de medicijnen in Nederland en – samen met Europese collega’s – voor de medicijnen in Europa.”

genetic testing

MRC holland

The importance of copy numbers in genetic diagnostics and research

MRC Holland has been paving the way to copy number confidence for over a decade. As the inventors and manufacturers of MLPA®, digitalMLPA™ and a Melt Assay for newborn screening, we supply the world with simple solutions to genetic inquiries.
MRC Holland develops tools for the detection of DNA copy numbers and
methylation patterns associated with disease. Our MLPA® technique is the gold standard in this field, and is used around the world to study hereditary disorders and tumours.
At MRC Holland, we believe that reliable genetic analysis should be available to everyone. Our mission is to provide the world with easy-to-use, high-quality and affordable genetic tools for diagnostic and research purposes.
We produce genetic tests for a wide variety of genes and applications. We make tests for highly prevalent disorders, but also for extremely rare ones. We do this because we believe that genetic tools should be available regardless of a disorder’s prevalence. As part of our commitment to keep genetic tests affordable, we offer products for rare disorders at the same price as our other products.
To have true impact, we operate in close collaboration with scientists around the world to develop new products and to improve existing ones. Results obtained with our products have been  described in thousands of scientific publications.
As a successful, growing biotechnology company located in Amsterdam-de Baarsjes, we offer a young, dynamic, and multi-national working environment. If you are passionate about providing the world with simple and affordable solutions to detect genetic aberrations, and enjoy a vibrant, family-friendly work environment: come join our team!
We take our social responsibilities seriously. A substantial part of our profit is invested in scientific (medical) research and spent on education and community projects in developing countries by the MRC Holland Foundation.

cancer therapy

Frame Cancer Therapeutics

Frame Cancer Therapeutics is a growing start-up dedicated to transforming the treatment of cancer by directing the immune system towards Frame neoantigens. We are developing personalized cancer immunotherapies, that are designed based on the Frame neoantigens uniquely encoded by the genome of each patient’s tumor. The company was founded in December 2018 and since then Frame has further strengthened the team with different expertise. Our personalized vaccine platform will soon be tested in the clinic (start in 2021) and the designing of new trials is being initiated. More information: www.frametherapeutics.com

Please note, there will be no open positions in the short term.

ai for healthcare


Your career at Medstone: building artificial intelligence solutions for healthcare and research. 

Reading and analysing scientific studies is an important part of your work. Whether you’re in your academic career, or (thinking of) pursuing a career as a researcher, pharmacist or doctor. At Medstone, we believe in the power of independent, scientific data. Which is why we’ve developed an algorithm that can automatically analyse complex scientific articles, and combine the results of multiple studies to give a complete overview of a drug or disease. Our algorithm combines several AI techniques (e.g. Named Entity Recognition and Semantic Dependency Parsing), and is used by medical doctors and pharmacists to make medical decisions, as well as by researchers in their research on personalised medicine.

Our team includes both experienced pharmacists and young researchers, and together we work on improving healthcare. Curious how we do this with the help of artificial intelligence? Join us during one of the online sessions at the online Amsterdam UMC career event!

Making Hospital Data Usable

CT cue

CTcue is a small flexible firm, rapidly growing in customers and content. Our goal is to make hospital data accessible and usable. Our main product is a search engine application for the Electronic Health Record (EHR) systems.

We have three engineering teams, Artificial Intelligence, Data warehousing and Software Development, and a team of medical data scientists. All of us are focused on bringing hospital data to life. There are huge challenges in these areas because patient data has vast numbers, is mostly unstructured and there is a big demand for insight.

  1. Artificial Intelligence. The main mission of the AI team is to extract medical concepts such as diagnoses, medication, and measurements from the electronic health records and present them structured to the users. Next to that the team creates solutions for the search application to help users do their work more efficiently.
  2. Data Warehousing. Data should be made available, standardised and easy usable. But also, it needs to be accurate, timely and complete. Every EHR system is different from the next. Combine that with billions of records and you can see the challenge we are facing.
  3. Search Application. Every Business Intelligence department can retrieve data from the EHR databases and data warehouses. But letting nurses, doctors and PhD students increase their efficiency and the speed with which they do research is a completely different field. We have built a search application that is usable not just by expert data managers, but by the people that actually need the data: the care providers and researchers.
  4. The same questions are being asked in hospitals all over the Netherlands but in isolation. Connecting with each other will increase the speed of research, increase the number of participants per study and thus the robustness of the research. Sharing knowledge and content between hospitals is key to patient value. Image what it means to the quality of healthcare when we succeed! Multicentre, distributed analyses are within reach. We achieve this while still adhering to laws and guidelines like the GDPR (AVG).

Bringing this all together, you can see CTcue is a small fish in this big ocean, but one with enormous impact and motivation to help improve healthcare.
 Feel the connection already: contact us at careers@ctcue.com



Sanofi is een biofarmaceutisch bedrijf dat zich bezig houdt met het voorkomen, behandelen en genezen van ziektes en aandoeningen gedurende je leven. Patiënten inspireren ons te blijven innoveren. We zetten ons dagelijks in om door middel van samenwerkingen met artsen, onderzoekers en patiënten innovaties mogelijk te maken en daarmee zorg op maat te bieden. Met het produceren van vaccins en medicijnen voor onder meer chronische en zeldzame ziekten, willen we hoop en verlichting bieden. Sanofi heeft de ambitie om wereldwijd een duurzame partner te zijn in de gezondheidszorg, waarbij we uitgaan van de behoeften van patiënten.

Ruim 100.000 medewerkers in meer dan 100 landen zetten zich dagelijks in om zorgoplossingen op basis van wetenschappelijke innovatie te bieden. De producten van Sanofi zijn verkrijgbaar in meer dan 170 landen.


Met een breed portfolio aan middelen helpen we zowel de kleine groepen patienten die te maken krijgen met een zeldzame ziekte als miljoenen mensen met langdurige chronische aandoeningen.
Bij Sanofi werken we in verschillende Business Units: Sanofi Genzyme, Sanofi Pasteur, General Medicines en Consumer Healthcare.


Sanofi Genzyme specialty care richt zich op zeldzame ziekten, zeldzame bloedziekten, multiple sclerose, oncologie en immunologie. We brengen therapieën die het verschil maken en daarmee hoop bieden aan patiënten en families. We zetten ons in voor de ontwikkeling en het beschikbaar maken van geneesmiddelen voor patiënten die nu nog niet, of niet voldoende, behandeld kunnen worden.


Sanofi Pasteur is de vaccins business unit binnen Sanofi. We geloven in een wereld waarin niemand lijdt of sterft aan een ziekte die door een vaccin voorkomen kan worden. Om die reden ontwikkelen we vaccins die ons en onze dierbaren helpen te beschermen tegen een breed scala aan ernstige infectieziekten in elke fase van het leven. We werken samen met de rijksoverheid en artsen aan de beschikbaarheid van vaccins voor iedereen die dat nodig heeft. Daarnaast zetten we ons in om door middel van vaccinatie de gezondheidsrisico’s op reis te verkleinen.


General Medicines wil het verloop van chronische ziekten veranderen. We zijn al een eeuw toonaangevend op het gebied van diabetes- en cardiovasculaire zorg. We combineren onze uitgebreide ervaring en portfolio van vertrouwde merken met de kracht van technologie en digitale innovatie. Het doel is om praktische zorgoplossingen te ontwikkelen die patienten in staat stellen op een geheel nieuwe manier met hun ziekte om te gaan


Consumer Healthcare stelt de eigen zorg voor gezondheid en welzijn centraal. Wij brengen zelfzorgoplossingen die mensen zonder tussenkomst van een arts zelf kunnen gebruiken. Binnen Consumer Healthcare focussen wij op de volgende gebieden: hoest en verkoudheid, gezonde spijsvertering en de groep vitamines, mineralen supplementen. Onze Consumer Healthcare middelen worden zonder recept bij drogisterijen, apotheken en in supermarkten verkocht.



Neem contact met ons op, klik hier

career developers


Bepaal je koers met DoctorConnect

Hoe maak je de juiste keuzes voor je carrière? Het werkveld is ontzettend breed, met op de ene plek schaarste en andere overschot. Wil je geen gouden beloftes maar een eerlijk advies op jóuw maat gesneden? Dáár maakt DoctorConnect het verschil.

Buiten de kliniek vind je een wereld aan kansen, met andere kenmerken en perspectieven.

Met meer balans in werk en privé. Ontdek jouw mogelijkheden in een speeddate met DoctorConnect!

Mail je vragen vooraf, dan daten we nóg sneller: info@doctorconnect.nl.


roland berger

From a single entrepreneur to one of the leading consultancies worldwide in nearly half a century. Roland Berger, founded in 1967, is one of the world’s leading strategy consultancies. It was and continues to be the only global strategy consultancy with European roots and we are growing very successfully. With around 2,400 employees working in 52 offices in 35 countries worldwide, we have successful operations in all major international markets. Roland Berger advises major international industry and service companies as well as public institutions. Our services cover all issues of strategic management – from strategy alignment and new business models, processes and organizational structures, to technology strategies. At Roland Berger, we develop customized, creative strategies together with our clients. We are right at home in the traditional consulting segments and are actively developing new markets. We support local companies on-site and support international corporations in entering and staying in new fields. We accept challenges wherever they emerge. In 2002 the Dutch office opened in the Amsterdam World Trade Center. 14 Consultants took on the challenge of setting up a new consulting firm in the Dutch market. The number of customers and employees grew rapidly. Driven by Roland Berger’s values Partnership, Excellence and Entrepreneurship, the Amsterdam office expanded from 14 to 90 employees in 10 years.


Gupta Strategists

Gupta Strategists is an independent consulting firm for organizations in the healthcare sector, in the Netherlands and abroad. We distill complex issues into practical solutions and innovative ideas.

Working at Gupta means you’ll be trained as an all-around strategy consultant. You’ll work on big projects with a small team, be continuously challenged and will develop into a strategic expert in the healthcare sector. Everything you do is with the goal of making our clients’ products and/or services better. Our recommendations are based on facts, supported by insights from our own (big data) research. Our work requires a flexible schedule, but comes with enormous job satisfaction and a sense of achievement.

Our team consists of 35 consultants and has a flat organizational structure. Our team is a mix of talented university graduates or PhD’s, and experienced hires from premium consulting firms.



myTomorrows is an international platform that links patients with an unmet medical need to treatments in development worldwide. myTomorrows works with physicians around the world to assist with the process of finding and accessing investigational drugs. They help partner pharmaceutical companies with patients and physicians in order to facilitate the development of the next generation of drugs.

medical technology


At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.

At our organization, you will find a diverse team of innovators who bring their unique backgrounds and their individual life experiences to work every day. We work hard to cultivate a workforce that reflects our patients and partners, we believe it’s the only way to drive healthcare forward. We want to attract a diverse workforce, regardless of age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, veteran status, or any other characteristic protected by state or local law. Join us and bring the power of your point of view to our culture of collaboration and innovation. It is through strong diversity, inclusion, and engagement that we can remain a leader in medical technology and solutions. And by embracing everything you have to offer —your unique perspectives, talents, and contributions —we can live up to the promise of our Mission.



Gadeta is a Research & Development company established in 2015 which focusses on the development of innovative immunotherapies for cancer. The work of the company is based on the groundbreaking discoveries regarding the role of γδ T cell receptors (TCRs) in the broad recognition of both hematological and solid tumor cells and their potential use for the treatment of advanced malignancies.



Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

One word for Genmab: Passion.